Illumina - maker of the DNA decoding system ... a valuable breakthrough in drug development. Despite being No. 2 in the DTC genetic testing market behind Ancestry, 23andMe has a big head start ...

Next-generation sequencing (NGS) technology, which has been used at Illumina since 2007, builds upon earlier genome sequencing methods to greatly reduce the time taken to sequence DNA. When the ...

DNA sequencing company Illumina and biotech Regeneron have invested in electronic health record data company Truveta to create the largest and most diverse database of genetic information in the ...

In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against other non-tech AI opportunities amid DeepSeek selloff. Investors are searching for safer ways to ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling subdued demand for its genetic tests and diagnostic tools, sending shares ...

The webinar is the first joint marketing initiative for ANGLE and Illumina. Because it harvests intact cancer cells (rather than DNA fragments of dead cells), ANGLE's Parsortix system offers the ...